Impact of Virtual Reality Technology on Pediatric Patients During Venous Access in the Emergency Department: A

Ling Lin1, Cui Zhu2, Lili Liu3

  • 1Department of Emergency.

Pediatric Emergency Care
|February 10, 2026
PubMed

Insights

Virtual reality (VR) technology in emergency departments (EDs) significantly reduced pain for pediatric patients during venous access. However, VR did not significantly decrease fear or improve first-attempt success rates in this patient group.

Area of Science:

  • Pediatric Emergency Medicine
  • Medical Technology Integration
  • Pain Management Innovations

Background:

  • Venous access is a common and often painful procedure for pediatric patients in emergency departments.
  • Minimizing procedural pain and anxiety is crucial for improving patient experience and cooperation.
  • Virtual reality (VR) has emerged as a potential non-pharmacological intervention for pain and anxiety management.

Purpose of the Study:

  • To systematically evaluate the effectiveness of virtual reality (VR) technology in managing pediatric patients undergoing venous access procedures within emergency departments (EDs).
  • To assess the impact of VR on pain, fear, and first-attempt success rates during pediatric venous access in the ED.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) were conducted.
  • Searches were performed across multiple databases (CNKI, Wanfang, VIP, CBM, PubMed, Cochrane Library, Embase, Web of Science) up to July 2025.
  • Data from 8 RCTs involving 629 pediatric patients were analyzed using RevMan 5.2 software.

Main Results:

  • Virtual reality technology demonstrated a statistically significant reduction in pain scores among pediatric patients compared to standard care (SMD=-0.73, P=0.04).
  • No significant differences were found in fear scores between the VR and control groups (SMD=-0.94, P=0.12).
  • The first-attempt success rate for venous access was not significantly improved by the use of VR technology (OR=1.01, P=0.96).

Conclusions:

  • Virtual reality technology shows promise as an adjunct for alleviating procedural pain in pediatric patients during venous access in emergency settings.
  • Current evidence does not support a significant benefit of VR in reducing patient fear or enhancing the likelihood of successful first-attempt venous access.
  • Further research may be needed to optimize VR interventions for comprehensive anxiety and procedural success in pediatric emergency care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
274
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
330
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
245
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
307
Emerging Adulthood01:27

Emerging Adulthood

Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
723
Virtual Work01:20

Virtual Work

The principle of virtual work states that if a body is in static and dynamic equilibrium, then the sum of all the virtual work done by all external forces and couple moments for any given virtual displacement must be zero.
In static equilibrium, a body can experience an imaginary or virtual movement, such as displacement or rotation. The virtual work done by a force is equal to the dot product of force and virtual displacement in the direction of the force. When it comes to virtually rotating a...
1.4K